Plug Power Inc.

According to the Complaint, the Company made false and misleading statements to the market. Plug overstated its ability to mitigate problems related to supply chain slowdowns and material shortages. The Company’s hydrogen production building plans continued to experience delays. The Company downplayed the extent of these issues. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Plug, investors suffered damages.

-->

Evolv Technologies Holdings, Inc.

According to the Complaint, the Company made false and misleading statements to the market. Evolv overstated the efficacy of its products. The Company’s products and their inability to effectively detect guns and knives led to an increase of undetected weapons entering sensitive locations such as schools. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Evolv, investors suffered damages.

-->

Shoals Technologies Group, Inc.

According to the Complaint, the Company made false and misleading statements to the market. Shoals failed to deliver electrical balance of system (“EBOS”) products at a high level of reliability and quality. The Company was aware that a large number of its EBOS systems used in solar fields were defective. The Company incurred costs of between $60 million and $185 million to remediate its defective products. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Shoals, investors suffered damages.

-->

The Chemours Company

According to the Complaint, the Company made false and misleading statements to the market. Chemours’ management team manipulated targets for free cash flow to maximize executive compensation under its Annual Incentive Plans and Long-Term Incentive Plans. The Company failed to maintain appropriate controls over financial reporting. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Chemours, investors suffered damages.

-->

Cassava Sciences, Inc.

According to the Complaint, the Company made false and misleading statements to the market. Cassava failed to maintain effective data management controls over its drug research programs. Due to this failure, the data reported in support of the Company’s drug candidate simufilam was susceptible to manipulation to overstate the drug’s efficacy. The Company misrepresented the commercial prospects of simufilam. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Cassava, investors suffered damages.

-->

agilon health, inc.

According to the Complaint, the Company made false and misleading statements to the market. The Company’s purported visibility into medical costs and utilization costs was touted by agilon’s management team. The Company failed to disclose the increased medical costs it had incurred due to higher utilization by Healthcare MA patients. The Company falsely stated its accounting reserves for higher utilization were adequate for its needs. The Company issued overly optimistic guidance for financial performance. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about agilon, investors suffered damages.

-->

SSR Mining Inc.

According to the Complaint, the Company made false and misleading statements to the market. SSR Mining overstated its commitment to safety and misrepresented the efficacy of its safety measures. The Company engaged in unsafe mining practices that increased the chances of a mining disaster. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about SSR Mining, investors suffered damages.

-->

Innoviz Technologies Ltd.

According to the Complaint, the Company made false and misleading statements to the market. Innoviz overstated the benefits of its alleged contracts and partnerships with automotive companies. The Company was unlikely to achieve the profitability it touted to investors. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Innoviz, investors suffered damages.

-->

Anavex Life Sciences Corp.

According to the Complaint, the Company made false and misleading statements to the market. Anavex provided investors with a materially inaccurate portrayal of its research program and the likelihood of product candidate blarcamesine succeeding in the “Excellence” Phase II/Phase III trial. The Company then announced the usage of the “MMRM” statistical methodology in the Excellence trial to analyze the study’s data, which ultimately failed to achieve statistical significance. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Anavex, investors suffered damages.

-->

iRobot Corporation

According to the Complaint, the Company made false and misleading statements to the market. iRobot’s merger with Amazon (“the Merger”) would give Amazon a dominant position in robot vacuum cleaners (“RVCs”), making it unlikely that American and European authorities would approve it. The Company failed to complete adequate due diligence on the Merger and ignored regulatory risks. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about iRobot, investors suffered damages.

-->